Press releases

March 1, 2024

ROME Therapeutics today announced that members of the ROME Senior Leadership Team will participate in the TD Cowen 44th Annual Health Care Conference.

January 4, 2024

ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer

December 14, 2023

ROME Publishes Landmark Nature Paper Revealing First High-Resolution Structure of LINE-1 Reverse Transcriptase (RT) for Drug Discovery

November 16, 2023

ROME Therapeutics Presents First Data to Validate LINE-1 RT as a Novel Target in Autoimmune Diseases and the Therapeutic Potential of its First-in-Class LINE-1 RT Inhibitors

Reveal more

News and events

April 17, 2024

Startups probe hidden viruses in the 'dark genome' to treat disease  |  Nature Biotechnology

April 2, 2024

Unlocking the Dark Genome for Lupus and Other Autoimmune Diseases  |  Unseen Upside, a podcast by Cambridge Associates

Reveal more

Scientific presentations

November 15, 2023

Elevated LINE-1 Expression in SLE Keratinocytes Leads to LINE-1 Reverse Transcriptase-dependent Type I Interferon Responses  |  ACR Convergence 2023

November 9, 2023

Mechanism-guided quantification of LINE-1 reveals p53 regulation of both retrotransposition and transcription  |  EMBO Workshop: The Mobile Genome

Reveal more